Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Regulatory News (COA)

Share Price Information for Coats (COA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.00
Bid: 82.00
Ask: 82.20
Change: -0.10 (-0.12%)
Spread: 0.20 (0.244%)
Open: 82.40
High: 82.40
Low: 81.40
Prev. Close: 82.10
COA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Rhenoflex

10 Aug 2022 16:36

RNS Number : 6130V
Coats Group PLC
10 August 2022
 

10 August 2022

Acquisition of Rhenoflex for 115m (c.$117m)

Complementary and synergistic addition to Texon, expanding Coats' leading position in the athleisure and sports footwear market

Coats Group plc ('Coats', the 'Group' or the 'Company'), the world's leading industrial thread manufacturer, is pleased to announce it has signed a definitive agreement to acquire 100% of Rhenoflex GmbH ('Rhenoflex'), one of the leading global manufacturers of sustainable structural material solutions for the footwear industry, for an enterprise value of 115m (c.$117m). Following the recent acquisition of Texon, this represents a synergistic bolt-on acquisition and a unique opportunity to strengthen Coats' position as a global leader in footwear components.

The consideration will be funded via the proceeds of an equity placing, of up to 10% of the Company's issued share capital (the "Placing"). The Placing is being conducted through an underwritten accelerated bookbuilding process which will be launched immediately following release of this announcement.

Transaction Highlights

· Acquisition of Rhenoflex consolidates Coats' presence in highly attractive and fast-growing athleisure and sports footwear market and strengthens positioning with key global footwear brands

· Highly complementary addition to Texon and Coats with complementary product offerings across footwear components and fashion accessories

· Combines two leading companies in structural footwear components with enhanced scale, reach and capability with attractive commercial opportunities to accelerate growth

· Strengthens platform with combined sales from Rhenoflex, Texon and Coats' Footwear and Accessories business at c.$425m on a last twelve-month basis to June 2022

· Enhances credentials in sustainability and expands breadth of sustainable product innovations with addition of in-house R&D team

· Significant value creation potential through realisation of cost synergies through efficiencies in procurement and back-office of $6m, incremental to $5m synergies from Texon, with combined synergies of $11m resulting from the two transactions

· Attractive purchase price represents 9.3x last twelve months to June 2022 EBITDA and 6.2x on a post-synergy basis

· Consideration to be funded via 10% equity placing, with leverage to remain within 1-2x target range maintaining strategic balance sheet flexibility

 

Strategic Rationale

Rhenoflex is a highly complementary addition to Texon, supplying high quality structural components to the premium global footwear market including heel counters, toe puffs, interlinings and eyelets, alongside sustainable material solutions for the luxury industry. Rhenoflex's strategic focus on sustainability together with its reputation as a technology leader, further enhances our portfolio of innovative offerings and strengthens our customer proposition to leading footwear brands.

The combination of Rhenoflex and Texon provides Coats with a compelling strategic opportunity to establish a global leader in the fragmented footwear and fashion accessories market, with significant combined growth opportunities through enhanced scale and capability. The acquisition is highly synergistic and expected to generate annual cost synergies of $6m through efficiencies in procurement and headcount. These are expected to be delivered by the end of the first full year of ownership with a one-off cash cost of $5m. Cost synergies from both Texon and Rhenoflex acquisitions are expected to total $11m. Integration of the business with Coats will be overseen by a dedicated team.

Transaction Structure

Under the terms of the transaction, Coats has agreed to pay an Enterprise Value of 115m (c.$117m), which represents total cash consideration of 107m (c.$110m) after deducting assumed retirement liabilities and other customary adjustments. This represents an attractive multiple of approximately 9.3x last twelve months to June 2022 EBITDA and 6.2x on a post-synergy basis.

The acquisition will be funded through an equity fundraising of up to 10 per cent of the Company's issued share capital, announced separately today. It is expected that following the placing, net leverage will remain well within our target range of 1-2x, maintaining our robust balance sheet for strategic flexibility. The combination of both Texon and Rhenoflex is EPS accretive to Coats from the first full year of ownership, whilst the acquisition of Rhenoflex on a standalone basis is marginally dilutive, given the equity placing. The acquisition is expected to complete by the end of August.

Rajiv Sharma, Coats Group Chief Executive, said:

"We are delighted to announce the acquisition of Rhenoflex, which presents an exciting and synergistic opportunity for Coats to establish a leading global platform in footwear components, expanding our presence in the fast-growing athleisure footwear market. Rhenoflex is a high quality business that is complementary to both Texon and Coats and its strategic focus on sustainability and innovation will significantly enhance our proposition to customers."

Lazard is acting as financial adviser to the Company.

A presentation for analysts and investors will be held at 5.00pm BST today, available via:

https://www.investis-live.com/coats/62f12fdd14e08212000bfdf3/po88

For further information please contact:

Coats Group plc

Nick Kidd

 

Lazard (Financial Adviser)

Richard Shaw / James Cliffe

 

FTI (Media)

Richard Mountain / Nick Hasell

+44 (0)20 8210 5090

 

 

+44 (0)20 7187 2000

 

 

 

+44 (0)20 3727 1374

 

Additional Information on Rhenoflex

Rhenoflex is a pioneer of sustainable reinforcement solutions in the footwear and lifestyle sector. The business supplies high quality structural footwear components including heel counters, toe puffs, interlinings and eyelets, alongside sustainable material solutions for the luxury industry. The business has a global footprint with manufacturing operations in Vietnam, China and Germany providing close proximity to major global footwear manufacturing hubs and luxury brands. For the year ended 31 December 2021, Rhenoflex reported revenue of c.65m (c.$66m) and operating profit of c.7m (c.$7m). Gross assets subject to the transaction are c.63m (c.$64m).

Important Notices

This announcement contains inside information for the purposes of the Market Abuse Regulation (Regulation (EU) No 596/2014) including as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018. This announcement is issued on behalf of the Company by Jackie Callaway, Chief Financial Officer at 4.36pm BST on 10 August 2022.

Lazard & Co., Limited ("Lazard"), which is authorised and regulated in the United Kingdom by the FCA, is acting as financial adviser to the Company, and no one else, in connection with the matters set out in this announcement, and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Lazard nor for providing advice in relation to the contents of this announcement or any other matter or arrangement referred to herein. Neither Lazard nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Lazard in connection with this announcement, any matter, arrangement or statement contained or referred to herein or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEASPEFAFAEFA
Date   Source Headline
5th Apr 202410:50 amRNSBlock listing Interim Review
25th Mar 20242:16 pmRNSDirector/PDMR Shareholding
25th Mar 20242:15 pmRNSDirector/PDMR Shareholding
13th Mar 20243:55 pmRNSAnnual Financial Report
8th Mar 202412:27 pmRNSDirector/PDMR Shareholding
8th Mar 202412:25 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNS2023 Full Year Results
29th Feb 202410:03 amRNSHolding(s) in Company
29th Feb 20249:59 amRNSHolding(s) in Company
14th Dec 20232:13 pmRNSDirector Declaration
7th Dec 20237:00 amRNSSwitch off of Pension Deficit Repair Payments
22nd Nov 20237:00 amRNSTrading Statement
21st Nov 20239:22 amRNSHolding(s) in Company
16th Nov 20232:02 pmRNSHolding(s) in Company
15th Nov 20239:00 amRNSChange of Senior Independent Director
1st Nov 20231:38 pmRNSHolding(s) in Company
9th Oct 202312:10 pmRNSBlock listing Interim Review
5th Oct 20237:00 amRNSDirectorate Change
27th Sep 202312:32 pmRNSDirector/PDMR Shareholding
25th Sep 20232:56 pmRNSHolding(s) in Company
14th Sep 202311:47 amRNSHolding(s) in Company
1st Sep 20237:00 amRNSDeal Completion
4th Aug 202311:54 amRNSDirector/PDMR Shareholding
4th Aug 202311:48 amRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSDivestment of European Zips
6th Jun 20239:00 amRNSAppointment of Joint Corporate Broker
22nd May 202310:28 amRNSDirector Declaration
17th May 20234:23 pmRNSResult of AGM
17th May 20237:00 amRNSTrading Statement
12th Apr 202312:47 pmRNSBlock listing Interim Review
27th Mar 20234:15 pmRNSHolding(s) in Company
22nd Mar 202312:39 pmRNSHolding(s) in Company
20th Mar 20232:41 pmRNSDirector/PDMR Shareholding
20th Mar 20232:40 pmRNSDirector/PDMR Shareholding
17th Mar 20234:44 pmRNSDirectorate Change
14th Mar 202312:38 pmRNSHolding(s) in Company
14th Mar 202312:25 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSDirector/PDMR Shareholding
9th Mar 202311:23 amRNSAnnual Financial Report
3rd Mar 202312:20 pmRNSDirector/PDMR Shareholding
3rd Mar 202312:17 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNS2022 Full Year Results
23rd Feb 202310:31 amRNSHolding(s) in Company
20th Feb 20237:00 amRNS$250m US private placement
16th Feb 20239:19 amRNSHolding(s) in Company
9th Dec 20229:23 amRNSHolding(s) in Company
6th Dec 20227:00 amRNSUK pension scheme update
23rd Nov 20227:00 amRNSTrading Statement
11th Nov 202211:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.